A phase Ib/II study of eribulin in combination with cyclophosphamide in patients with advanced breast cancer. Read more about A phase Ib/II study of eribulin in combination with cyclophosphamide in patients with advanced breast cancer.
Digital mammography and digital breast tomosynthesis for detecting invasive lobular and ductal carcinoma. Read more about Digital mammography and digital breast tomosynthesis for detecting invasive lobular and ductal carcinoma.
Quantifying hormone receptor status in lobular breast cancer in an institutional series: the relationship between estrogen and progesterone receptor status and outcomes. Read more about Quantifying hormone receptor status in lobular breast cancer in an institutional series: the relationship between estrogen and progesterone receptor status and outcomes.
Association of baseline ROR1 and ROR2 gene expression with clinical outcomes in the I-SPY2 neoadjuvant breast cancer trial. Read more about Association of baseline ROR1 and ROR2 gene expression with clinical outcomes in the I-SPY2 neoadjuvant breast cancer trial.
HER-2 low status in early-stage invasive lobular carcinoma of the breast: associated factors and outcomes in an institutional series. Read more about HER-2 low status in early-stage invasive lobular carcinoma of the breast: associated factors and outcomes in an institutional series.
Outcomes and clinicopathologic characteristics associated with disseminated tumor cells in bone marrow after neoadjuvant chemotherapy in high-risk early stage breast cancer: the I-SPY SURMOUNT study. Read more about Outcomes and clinicopathologic characteristics associated with disseminated tumor cells in bone marrow after neoadjuvant chemotherapy in high-risk early stage breast cancer: the I-SPY SURMOUNT study.
Clinical characteristics and outcomes in patients with metastatic breast cancer and pseudocirrhosis: a single center retrospective cohort study. Read more about Clinical characteristics and outcomes in patients with metastatic breast cancer and pseudocirrhosis: a single center retrospective cohort study.
Patient-centered dosing: oncologists' perspectives about treatment-related side effects and individualized dosing for patients with metastatic breast cancer (MBC). Read more about Patient-centered dosing: oncologists' perspectives about treatment-related side effects and individualized dosing for patients with metastatic breast cancer (MBC).
Trophoblast Cell Surface Antigen 2 gene (TACSTD2) expression in primary breast cancer. Read more about Trophoblast Cell Surface Antigen 2 gene (TACSTD2) expression in primary breast cancer.
Decision quality and regret with treatment decisions in women with breast cancer: Pre-operative breast MRI and breast density. Read more about Decision quality and regret with treatment decisions in women with breast cancer: Pre-operative breast MRI and breast density.
